FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620247735> ?p ?o ?g. }

• W2620247735 endingPage "87" @default.
• W2620247735 startingPage "77" @default.
• W2620247735 abstract "Parkinson's disease (PD) is a progressive neurological disorder, mainly characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. Although the cause of PD remains elusive, mitochondrial dysfunction and severe oxidative stress are strongly implicated in the cell death that characterizes the disease. Under oxidative stress, the master regulator of cellular redox status, nuclear factor erythroid 2 related factor 2 (Nrf2), is responsible for activating the transcription of several cytoprotective enzymes, namely glutathione peroxidase (GPx) and heme oxygenase-1 (HO-1). Nrf2 is a promising target to limit reactive oxygen species (ROS)-mediated damage in PD. Here, we show that tauroursodeoxycholic acid (TUDCA) prevents both 1-methyl-4-phenylpyridinium (MPP+)- and α-synuclein-induced oxidative stress, through Nrf2 activation, in SH-SY5Y cells. Additionally, we used C57BL/6 male mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to elucidate the effect of TUDCA in this in vivo model of PD. In vivo, TUDCA treatment increases the expression of Nrf2, Nrf2 stabilizer DJ-1, and Nrf2 downstream target antioxidant enzymes HO-1 and GPx. Moreover, we found that TUDCA enhances GPx activity in the brain. Altogether, our results suggest that TUDCA is a promising agent to limit ROS-mediated damage, in different models of PD acting, at least in part, through modulation of the Nrf2 signaling pathway. Therefore, TUDCA should be considered a promising therapeutic agent to be implemented in PD." @default.
• W2620247735 created "2017-06-05" @default.
• W2620247735 creator A5001608882 @default.
• W2620247735 creator A5012175198 @default.
• W2620247735 creator A5014020587 @default.
• W2620247735 creator A5015416179 @default.
• W2620247735 creator A5015633310 @default.
• W2620247735 creator A5017275901 @default.
• W2620247735 creator A5018228138 @default.
• W2620247735 creator A5040643475 @default.
• W2620247735 creator A5041222469 @default.
• W2620247735 creator A5056732832 @default.
• W2620247735 creator A5056903985 @default.
• W2620247735 date "2017-09-01" @default.
• W2620247735 modified "2023-10-15" @default.
• W2620247735 title "Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease" @default.
• W2620247735 cites W1486636074 @default.
• W2620247735 cites W1587279255 @default.
• W2620247735 cites W1588992136 @default.
• W2620247735 cites W1974540289 @default.
• W2620247735 cites W1974843588 @default.
• W2620247735 cites W1977334935 @default.
• W2620247735 cites W1979458217 @default.
• W2620247735 cites W1980739328 @default.
• W2620247735 cites W1984332363 @default.
• W2620247735 cites W1989320614 @default.
• W2620247735 cites W1989498664 @default.
• W2620247735 cites W1990056937 @default.
• W2620247735 cites W1990346703 @default.
• W2620247735 cites W1991966760 @default.
• W2620247735 cites W1993794517 @default.
• W2620247735 cites W1994688096 @default.
• W2620247735 cites W1999148207 @default.
• W2620247735 cites W2001251350 @default.
• W2620247735 cites W2004280801 @default.
• W2620247735 cites W2004381553 @default.
• W2620247735 cites W2005971787 @default.
• W2620247735 cites W2007635795 @default.
• W2620247735 cites W2012112859 @default.
• W2620247735 cites W2021815999 @default.
• W2620247735 cites W2029102160 @default.
• W2620247735 cites W2030754641 @default.
• W2620247735 cites W2034424279 @default.
• W2620247735 cites W2036773337 @default.
• W2620247735 cites W2048570076 @default.
• W2620247735 cites W2049710822 @default.
• W2620247735 cites W2055285423 @default.
• W2620247735 cites W2062845561 @default.
• W2620247735 cites W2064428225 @default.
• W2620247735 cites W2077567337 @default.
• W2620247735 cites W2080750411 @default.
• W2620247735 cites W2083790644 @default.
• W2620247735 cites W2086692195 @default.
• W2620247735 cites W2090060443 @default.
• W2620247735 cites W2090792221 @default.
• W2620247735 cites W2091404872 @default.
• W2620247735 cites W2118898883 @default.
• W2620247735 cites W2130497877 @default.
• W2620247735 cites W2133398254 @default.
• W2620247735 cites W2141322891 @default.
• W2620247735 cites W2146454538 @default.
• W2620247735 cites W2149959669 @default.
• W2620247735 cites W2225098388 @default.
• W2620247735 cites W2337964991 @default.
• W2620247735 cites W2530829140 @default.
• W2620247735 cites W340359662 @default.
• W2620247735 cites W4246230178 @default.
• W2620247735 cites W826091804 @default.
• W2620247735 doi "https://doi.org/10.1016/j.expneurol.2017.05.009" @default.
• W2620247735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28552716" @default.
• W2620247735 hasPublicationYear "2017" @default.
• W2620247735 type Work @default.
• W2620247735 sameAs 2620247735 @default.
• W2620247735 citedByCount "65" @default.
• W2620247735 countsByYear W26202477352017 @default.
• W2620247735 countsByYear W26202477352018 @default.
• W2620247735 countsByYear W26202477352019 @default.
• W2620247735 countsByYear W26202477352020 @default.
• W2620247735 countsByYear W26202477352021 @default.
• W2620247735 countsByYear W26202477352022 @default.
• W2620247735 countsByYear W26202477352023 @default.
• W2620247735 crossrefType "journal-article" @default.
• W2620247735 hasAuthorship W2620247735A5001608882 @default.
• W2620247735 hasAuthorship W2620247735A5012175198 @default.
• W2620247735 hasAuthorship W2620247735A5014020587 @default.
• W2620247735 hasAuthorship W2620247735A5015416179 @default.
• W2620247735 hasAuthorship W2620247735A5015633310 @default.
• W2620247735 hasAuthorship W2620247735A5017275901 @default.
• W2620247735 hasAuthorship W2620247735A5018228138 @default.
• W2620247735 hasAuthorship W2620247735A5040643475 @default.
• W2620247735 hasAuthorship W2620247735A5041222469 @default.
• W2620247735 hasAuthorship W2620247735A5056732832 @default.
• W2620247735 hasAuthorship W2620247735A5056903985 @default.
• W2620247735 hasConcept C126322002 @default.
• W2620247735 hasConcept C134018914 @default.
• W2620247735 hasConcept C137183658 @default.
• W2620247735 hasConcept C139447449 @default.
• W2620247735 hasConcept C158617107 @default.

• next